Cargando...
Management of Morgellons Disease With Low-Dose Trifluoperazine
This medical record review examines the novel use of low-dose trifluoperazine, a high-potency typical antipsychotic, in a cohort of patients with Morgellons disease.
Guardado en:
| Publicado en: | JAMA Dermatol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Medical Association
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5839272/ https://ncbi.nlm.nih.gov/pubmed/29322188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2017.5175 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|